Lilybelle Abraham is a corporate partner in the New York office of Kirkland & Ellis LLP. Her practice focuses on M&A and private equity transactions, advising public companies and private equity sponsors in a variety of complex transactions, including mergers, acquisitions and dispositions and private equity transactions. She also counsels clients with respect to general corporate matters.
Experience
Representative Matters
Prior to joining Kirkland, Lilybelle was involved in the following matters:
DuPont de Nemours, Inc. in various transactions, including its:
$21 billion spin-off of Qnity Electronics, Inc.
$1.75 billion acquisition of Spectrum Plastics.
BioCryst Pharmaceuticals, Inc. in the sale of its European ORLADEYO® business.
Mubadala Investment Company PJSC as one of the lead co-investors with Silver Lake in the going-private acquisition of Endeavor Group Holdings, Inc. at an enterprise value of $25 billion.
Revance Therapeutics in connection with several transactions, including its:
$924 million merger with Crown Laboratories.
$325 million commercial agreement amendment with Teoxane S.A.
BlackRock’s sale of its stake in Authentic Brands Group to a consortium including CVC Capital Partners, General Atlantic and HPS Investment Partners.
Downtown Music Holdings LLC in its $775 million acquisition by Virgin Music Group.
Squarespace, Inc. in its $7.2 billion going-private acquisition by Permira Advisers.
Trane Technologies in its acquisition of Nuvolo.
Castik Capital in the combination of its portfolio company Waterlogic Group Holdings with Culligan International, a BDT Capital portfolio company.
International Flavors & Fragrances’ divestiture of its Pharma Solutions business unit to Roquette.
Clerk & Government Experience
Judicial Law ClerkHonorable Joseph R. Slights, IIIDelaware Court of Chancery2018–2019
